

1,2-二油酰-SN-甘油-3-磷酰乙醇胺
产品简称:DOPECAS no.:4004-05-1| CAS no. | 分子量(Mp) | 产品编码 |
| 4004-05-1 | 744 | 06030000500 |
CDE登记号:F20210000586;DMF登记号:038416
查库存 / 立即抢购:因官网暂不支持直接下单,可点击链接跳转至商城选购,一键锁定现货
即刻跳转

相关文献:
1. Li L, Luo M, Zhou L, et al. Glucocorticoid pre-administration improves LNP-mRNA mediated protein replacement and genome editing therapies. Int J Pharm. 2025;672:125282. doi:10.1016/j.ijpharm.2025.125282
2. Ren L, Zhao Z, Chao Y, et al. Optimization of Lipid Nanoparticles with Robust Efficiency for the Delivery of Protein Therapeutics to Augment Cancer Immunotherapy. Adv Sci (Weinh). 2025;12(17):e2500844. doi:10.1002/advs.202500844
3. Lin X, Chen G, Tang R, Wu M, Zhang D, Lin F, Guan J, Yang J, Dong X, Zheng X, Qiu L, Yu H, Cai Z, Liu X. Spleen-targeted neoantigen mRNA vaccine induces ISG15+ CD8+ T cell-mediated tertiary lymphoid structure formation in hepatocellular carcinoma. Cell Rep Med. 2026 May 19;7(5):102754. doi: 10.1016/j.xcrm.2026.102754. Epub 2026 Apr 20. PMID: 42013842; PMCID: PMC13198314.
4. Zong Y, Zhong H, Wang Y, Lin Y, Zhao L, Wang X, Cai J, Lin H, Xiao Y, Wei T, Guo S, Cheng Q. Safe and Highly Efficient Lipid-Pro-Dexamethasone Nanoparticles for mRNA Delivery and Base Editing. J Am Chem Soc. 2026 Mar 11;148(9):10225-10240. doi: 10.1021/jacs.6c01708. Epub 2026 Feb 24. PMID: 41733506.
5. Zong Y, Wang Y, Lin Y, Li Q, Li M, Ren H, Wang X, Ma Q, Yu X, Hu R, Wei T, Cheng Q. Synergistic targeted (SynTar) lipid nanoparticles enhance the efficacy and specificity of mRNA delivery in lungs. Acta Pharm Sin B. 2026. doi:10.1016/j.apsb.2026.01.002. Epub ahead of print.
6. Chang T, Zheng Y, Jiang M, Jia S, Bai J, Zheng Z, Li S, Guo J, Wang Y, Wang Y, Liu H, Liu J, Ni L, Cheng X, Liu S, Zhang H, Pi W, Lin F, Liu S, Wang W, Wang G, Wang L, Miao L, Lu X, Deng Z, Bai B, Qin Z, Gao H, Shao Y. Peptide codes for organ-selective mRNA delivery. Nat Mater. 2026 Jan;25(1):146-159. doi: 10.1038/s41563-025-02331-6. Epub 2025 Sep 1. PMID: 40890497.
关键词:新冠疫苗辅料mRNA疫苗辅料12-dioleoyl-sn-glycero-3-phosphoethanolamine厦门赛诺邦格致力于药物释放系统工作,为全球的制药和医疗器械公司提供产品、技术与服务。我们的工厂通过了ISO9001和ISO13485认证,并按照ICH-Q7A(FDA原料药GMP指南)组织生产产品。
我们的网站可能没有完全列出所有产品,更多产品请致电:0592-7761068
我们同时向所有客户提供定制合成的服务,也可邮箱联系:sales@sinopeg.com
















